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Letters to the Editor
The journal publishes both invited and unsolicited letters.
NON-MEDICAL USE OF PRESCRIPTION
OPIOIDS IS ASSOCIATED WITH HEROIN
INITIATION AMONG US VETERANS
We read with interest the article by Banerjee and
colleagues [1], entitled ‘Non-medical use of prescription
opioids is associated with heroin initiation among US
veterans: a prospective cohort study’, published in
Addiction. The authors aimed to estimate the inﬂuence
of non-medical use of prescription opioids (NMUPO) on
heroin initiation among US veterans. They analyzed data
from a prospective, multi-site, observational study of
HIV-infected and an age/race/site-matched control group
of HIV-uninfected veterans. A total of 3396 HIV-infected
and uninfected patients were enrolled into the study.
They found that non-medical use of prescription opioids
(NMUPO) was associated positively and independently
with heroin initiation. Banerjee et al. conclude that
new-onset NMUPO is a strong risk factor for heroin
initiation among HIV-infected and uninfected veterans
in the United States [1].
We would like to comment that the major weakness of
the study may be the sample bias, as the study used the
subpopulation of VA patients who received care for
infectious diseases such as HIV, hepatitis C virus (HCV)
and others.
In 2014, a total of 10.3 million people reported using
prescription opioids non-medically [2]. There was a
signiﬁcant decrease in the total number of non-medical
use of prescription opioids (NMUPO) compared to 2010
(estimated 12.2 million) [3]. Paradoxically, the drop of
1.9 million NMUPO has not resulted in any improvement, neither in opioid mortality nor prevalence of
heroin abuse or heroin mortality [4]. Ironically, there
has been a signiﬁcant increase in opioid overdose-related
mortality, i.e. 16 007 deaths in 2012 but 18 893 deaths
in 2014; namely, an 18% increase [5]. The number of
people who used heroin peaked to 914 000 in 2014
versus 373 000 in 2007, a 145% increase [4]. Further,
mortality related to heroin overdose has more than quintupled, from 1842 in 2000 to 10 574 deaths in 2014
[2], which is 2317 more than cited in Banerjee et al.’s
[1] report.
In a recent review paper [6] entitled ‘Relationship
between nonmedical prescription-opioid use and heroin
use’, published in the New England Journal of Medicine,
Compton et al. [6] opined that only a small percentage of
non-medical users of prescription opioids initiate heroin
use: ‘… the available data suggest that NMUPO is neither
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necessary nor sufﬁcient for the initiation of heroin use…’.
Indeed, Muhuri et al. found that 3.6% of non-medical users
initiated heroin use within 5 years after beginning nonmedical use of prescription opioids [7].
As acknowledged by Banerjee et al., ‘the study enrolled individuals who are probably at higher risk for heroin initiation than the general veteran population’,
therefore their results should not be generalized to other
VA patients, as the title of the paper reﬂects. Indeed, a
study of new HCV infections in Massachusetts found that
95% of interview respondents used prescription opioids
before initiating heroin [8]. One study suggests that using
opioid pain relievers before transitioning to heroin injection is a common trajectory for young injection drug
users with HCV infection [9]. This may be the underlying
reason that the rate of heroin initiation in nonHIV-exposed is signiﬁcantly higher than the rate observed
among US adults.
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REPLY TO RUAN ET AL. (2017): NON-MEDICAL
USE OF PRESCRIPTION OPIOIDS IS
ASSOCIATED WITH HEROIN INITIATION
AMONG US VETERANS
We thank Ruan and colleagues for their letter and
appreciate their comments regarding our recent
study [1], which demonstrated an independent association between non-medical use of prescription opioids
(NMUPO) and heroin initiation among US veterans [2].
Our results indicate that participants who reported prior
or concurrent NMUPO had 5.43 times the adjusted hazard of heroin initiation, compared to participants who
reported no NMUPO [95% conﬁdence interval
(CI) = 4.01–7.35]. While we acknowledge in our paper
that these results are not necessarily generalizable to all
US veterans, given the inclusion of participants who are
HIV-infected and/or hepatitis C virus (HCV)-infected, the
observed effect of NMUPO on risk for heroin initiation
was robust to sensitivity analyses. For example, as described in our published study, excluding the 701 HCVpositive participants did not affect the result [adjusted
hazard ratio (AHR) = 6.21, 95% conﬁdence interval
(CI) = 4.54–8.51)] meaningfully. In light of the concerns
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raised by Ruan and colleagues, we repeated the analysis
excluding HIV-infected individuals, and in fact found
that the relationship between NMUPO and heroin initiation was stronger (AHR = 7.01, 95% CI = 5.40–9.09).
Thus, although the observed absolute rate of heroin
initiation may be greater than in the general US veteran
population due to the speciﬁc inclusion of higher-risk patients, it does not appear that the relationship between
NMUPO and heroin initiation is affected by HCV or
HIV prevalence.
Ruan and colleagues also highlighted the increase in
heroin-related deaths from 2013 to 2014, with the concurrent decrease in people reporting non-medical use of
prescription opioids. This inverse relationship may, in
fact, be attributable to the fact that large numbers of
people who developed opioid use disorder (as a result of
non-medical use of prescription opioids) have transitioned
subsequently to heroin use [3,4]. The trend between
increased rates of death associated with heroin use and
decreased rates of death associated with use of prescription opioids thus speaks to the potential role of
transitioning from the misuse of prescription opioids to
the use of heroin in many parts of the country [5,6].
This phenomenon is consistent with the ﬁndings of our
paper, given that NMUPO may be one step in a complex,
multi-step cascade that increases risk of transition to
heroin use in the population [7,8].
Additionally, while Compton and colleagues noted
that: ‘only a small percentage of non-medical users of
prescription opioids initiate heroin use’, they also go on
to say that: ‘given the large number of nonmedical
users, even a small percentage who initiate heroin use
translates into several hundred thousand new heroin
users’ [9]. Ruan et al. cite a statistic that 3.6% of the
people reporting NMUPO initiated heroin use within
5 years of beginning NMUPO. Indeed, even this small
percentage, if correct, would result in approximately
370 800 individuals initiating heroin use by 2019. Prior
and subsequent years would contribute similar
proportions of individuals initiating heroin due to
NMUPO [10].
In conclusion, we appreciate that the rates of heroin
initiation in our study are potentially higher compared to
rates of heroin initiation among studies that do not include
HIV- and HCV-infected veterans. However, this limitation
does not obscure the primary ﬁndings of our study, which
speaks to the observed increased relative risk of heroin
initiation among participants who report prior/concurrent
NMUPO compared to participants who report no prior/
concurrent NMUPO.
Declaration of interests
None.
Addiction, 112, 727–732

